Familial adenomatous polyposis epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 7: | Line 7: | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The incidence familial adenomatous polyposis is approximately 12 per 100,000 births in the | *The incidence familial adenomatous polyposis is approximately 12 per 100,000 births in the Europe.<ref name="HalfBercovich2009">{{cite journal|last1=Half|first1=Elizabeth|last2=Bercovich|first2=Dani|last3=Rozen|first3=Paul|title=Familial adenomatous polyposis|journal=Orphanet Journal of Rare Diseases|volume=4|issue=1|year=2009|pages=22|issn=1750-1172|doi=10.1186/1750-1172-4-22}}</ref> | ||
* | * | ||
===Prevalence=== | ===Prevalence=== | ||
*The | *The prevalence of familial adenomatous polyposis is approximately 2.5-8.5 per 100,000 individuals in the Europe. | ||
*In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | *In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide. | ||
*The prevalence of [disease/malignancy] is estimated to be [number] cases annually. | *The prevalence of [disease/malignancy] is estimated to be [number] cases annually. | ||
| Line 30: | Line 30: | ||
*[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. | *[Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name]. | ||
===Gender=== | ===Gender=== | ||
* | *Familial adenomatous polyposis affects men and women equally.<ref name="HalfBercovich2009">{{cite journal|last1=Half|first1=Elizabeth|last2=Bercovich|first2=Dani|last3=Rozen|first3=Paul|title=Familial adenomatous polyposis|journal=Orphanet Journal of Rare Diseases|volume=4|issue=1|year=2009|pages=22|issn=1750-1172|doi=10.1186/1750-1172-4-22}}</ref> | ||
===Region=== | ===Region=== | ||
* | *Familial adenomatous polyposis is a rare disease that is worldwide. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 16:48, 26 January 2018
|
Familial adenomatous polyposis Microchapters |
|
Differentiating Familial adenomatous polyposis from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Familial adenomatous polyposis epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Familial adenomatous polyposis epidemiology and demographics |
|
FDA on Familial adenomatous polyposis epidemiology and demographics |
|
CDC on Familial adenomatous polyposis epidemiology and demographics |
|
Familial adenomatous polyposis epidemiology and demographics in the news |
|
Blogs on Familial adenomatous polyposis epidemiology and demographics |
|
Directions to Hospitals Treating Familial adenomatous polyposis |
|
Risk calculators and risk factors for Familial adenomatous polyposis epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Sadaf Sharfaei M.D.[2], Mohamad Alkateb, MBBCh [3]
Overview
Epidemiology and Demographics
Incidence
- The incidence familial adenomatous polyposis is approximately 12 per 100,000 births in the Europe.[1]
Prevalence
- The prevalence of familial adenomatous polyposis is approximately 2.5-8.5 per 100,000 individuals in the Europe.
- In [year], the incidence/prevalence of [disease name] was estimated to be [number range] cases per 100,000 individuals worldwide.
- The prevalence of [disease/malignancy] is estimated to be [number] cases annually.
Case-fatality rate/Mortality rate
- In [year], the incidence of [disease name] is approximately [number range] per 100,000 individuals with a case-fatality rate/mortality rate of [number range]%.
- The case-fatality rate/mortality rate of [disease name] is approximately [number range].
Age
- Patients of all age groups may develop [disease name].
- The incidence of [disease name] increases with age; the median age at diagnosis is [#] years.
- [Disease name] commonly affects individuals younger than/older than [number of years] years of age.
- [Chronic disease name] is usually first diagnosed among [age group].
- [Acute disease name] commonly affects [age group].
Race
- There is no racial predilection to [disease name].
- [Disease name] usually affects individuals of the [race 1] race. [Race 2] individuals are less likely to develop [disease name].
Gender
- Familial adenomatous polyposis affects men and women equally.[1]
Region
- Familial adenomatous polyposis is a rare disease that is worldwide.